4.5 Article

Clinical Decision Support Systems Could Be Modified To Reduce 'Alert Fatigue' While Still Minimizing The Risk Of Litigation

期刊

HEALTH AFFAIRS
卷 30, 期 12, 页码 2310-2317

出版社

PROJECT HOPE
DOI: 10.1377/hlthaff.2010.1111

关键词

-

资金

  1. Agency for Healthcare Research and Quality [K08HS18465-01, HS11169-01]
  2. Robert Wood Johnson Foundation
  3. Health Information Technology Center for Education and Research in Therapeutics
  4. National Health Service (NHS)
  5. Medical Research Council

向作者/读者索取更多资源

Clinical decision support systems-interactive computer systems that help doctors make clinical choices-can reduce errors in drug prescribing by offering real-time alerts about possible adverse reactions. But physicians and other users often suffer alert fatigue caused by excessive numbers of warnings about items such as potentially dangerous drug interactions. As a result, they may pay less attention to or even ignore some vital alerts, thus limiting these systems' effectiveness. Designers and vendors sharply limit the ability to modify alert systems because they fear being exposed to liability if they permit removal of a warning that could have prevented a harmful prescribing error. Our analysis of product liability principles and existing research into the use of clinical decision support systems, however, finds that more finely tailored or parsimonious warnings could ease alert fatigue without imparting a high risk of litigation for vendors, purchasers, and users. Even so, to limit liability in this area, we recommend stronger government regulation of clinical decision support systems and development of international practice guidelines highlighting the most important warnings.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据